Physician
Flores, Libertad
Flores, Libertad was paid $1.07M by Medicaid between Sep 2018 and Dec 2024, across 50 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.
33Billing provider infoFLORES, LIBERTAD
PROVIDENCE, RI 02907
PROVIDENCE, RI 02907
33aNPI1437564028assigned 06/23/2014
33bProvider typeObstetrics & Gynecology Physician
28Total paid$1.07M
24GClaims10,563
24DCodes billed50
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Rhode Island
Rank by total paid#5 of 106
Median peer was paid$8K
This provider vs. median129×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39 | $2K | |
| 2019 | 54 | $2K | |
| 2020 | 81 | $97K | |
| 2021 | 345 | $269K | |
| 2022 | 827 | $71K | |
| 2023 | 4,582 | $311K | |
| 2024incomplete | 4,635 | $317K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 336 | 316 | $340K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.2% | 430 | 416 | $66K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.7% | 1,453 | 1,306 | $61K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 48 | 47 | $59K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4.4% | 417 | 406 | $47K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.2% | 427 | 412 | $45K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 440 | 426 | $36K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.3% | 549 | 537 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 710 | 677 | $31K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.7% | 297 | 252 | $29K |
| 86780 | 2.3% | 435 | 422 | $25K | |
| 86481 | 1.9% | 142 | 139 | $21K |
38 more codes
| 86850 | 1.9% | 240 | $20K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1.7% | 344 | $18K |
| 86803 | 1.6% | 138 | $17K | |
| 86787 | 1.6% | 155 | $17K | |
| 86762 | 1.6% | 155 | $17K | |
| 59426 | 1.6% | 25 | $17K | |
| 86900 | 1.5% | 240 | $16K | |
| 86901 | 1.5% | 240 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 142 | $14K |
| 83020 | 1.2% | 75 | $13K | |
| 76801 | <1% | 247 | $10K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 67 | $10K |
| 59430 | <1% | 87 | $9K | |
| 87340 | <1% | 105 | $9K | |
| 81001 | <1% | 149 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 419 | $8K |
| 83021 | <1% | 75 | $7K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 83 | $6K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 25 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 76 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 138 | $4K |
| 82950 | <1% | 136 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 515 | $4K |
| 59025 | Fetal non-stress test | <1% | 113 | $3K |
| 82105 | <1% | 53 | $3K | |
| 81025 | <1% | 532 | $2K | |
| 84702 | <1% | 26 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 39 | $2K |
| 87150 | <1% | 19 | $2K | |
| 82677 | <1% | 12 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 36 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 26 | $1K |
| 99283 | Emergency room visit (moderate) | <1% | 12 | $697.66 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 14 | $610.10 |
| 86336 | <1% | 12 | $433.32 | |
| 81002 | <1% | 79 | $144.76 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $89.10 |
| 87210 | <1% | 18 | $70.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.